Centre For Research Excellence In Developmental And Epileptic Encephalopathies
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
We will study the clinical, genetic and psychological aspects of patients with the most severe group of epilepsies, the Developmental and Epileptic Encephalopathies (DEEs). We will define the clinical spectrum of each genetic DEE, improve health outcomes through understanding the natural history of these diseases, build an integrated model of care, produce family resources and assess health economic impacts. This program will ensure Australia is poised for emerging Precision Medicine trials.
We aim to find the right treatment for children and adults with inflammatory arthritis to give the best path to symptom relief with least risk of side effects. We will build on our national data-base and biospecimens bank (A3BC-ARAD) to collect a broad range of patient-reported, biological, environmental and health information to unlock the answers using big-data analysis. We will build a resource and workforce to continue to look for cures to deliver the best outcomes for patients and society.
Dental Health Services Research For Improved Oral Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$2,641,484.00
Summary
This research will generate new knowledge to improve health outcomes by investigating expenditure and financing of dental care, dental practice performance, and the impact of dental services on oral health outcomes. This is needed for health policy to deliver dental care that promotes good oral health, to identify characteristics of the dental delivery system that deliver productive outputs with good outcomes, and testing oral health outcomes in relation to the type of dental care received.
A Centre For Research Excellence In Cerebral Palsy (CRE-CP)
Funder
National Health and Medical Research Council
Funding Amount
$2,622,042.00
Summary
Cerebral palsy is the most common physical disability in childhood. Our objective is to bring about a radical improvement in the treatment of individuals with cerebral palsy, both children and adults, and to determine better ways to assist their families. Emphasis will be placed on early detection of health issues and rigorous evaluation of management options. We will train more researchers and ensure that all the knowledge generated is made available to families and health care professionals.
Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network
Funder
National Health and Medical Research Council
Funding Amount
$2,497,654.00
Summary
Arthritis and musculoskeletal conditions place an immense and growing burden on the world’s population. They affect 28% of Australians (>6.1 million people). With the support of CRE funding, the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network will optimise musculoskeletal health through high quality, collaborative clinical research, building research capacity and effective transfer of research outcomes into clinical practice and health policy.
Australian Resuscitation Outcomes Consortium [AUS-ROC] CRE
Funder
National Health and Medical Research Council
Funding Amount
$2,668,571.00
Summary
The Australian Resuscitation Outcomes Consortium (Aus-ROC) will be modelled on the highly successful North American Resuscitation Outcomes Consortium. The mission of Aus-ROC will be to conduct clinical trials and observational studies into the emergency management of out-of-hospital cardiopulmonary arrest. Building on our existing collaborative partnerships, our goal is to improve patient outcomes and build the research capacity in prehospital emergency care.
National Centre Of Research Excellence To Improve Management Of Peripheral Arterial Disease
Funder
National Health and Medical Research Council
Funding Amount
$2,618,637.00
Summary
Approximately 15% of adults have blockages or weakness of major arteries in the periphery, associated with impaired quality of life and a high mortality. Significant management deficiencies for these problems include limited diagnostic, prognostic and treatment options, as well as poor adoption of evidence based practice. The proposed national centre will bring together a group of experts in the field to instigate a number of initiatives to improve patient management.
Centre Of Research Excellence In Medicines And Ageing
Funder
National Health and Medical Research Council
Funding Amount
$2,601,415.00
Summary
Medicines have an important place in health and are commonly used for long periods, sometimes life-long. Using medicines wisely requires a careful balance between benefits and harmful effects. Currently, there is limited information to guide medicines use over a lifetime. Using large linked datasets, the CRE in Medicines and Ageing will generate much needed evidence about real world medicines use to support clinical and pharmaceutical policy decisions.
Breathe Well: A Centre For Research Excellence In Chronic Respiratory Diseases And Lung Ageing
Funder
National Health and Medical Research Council
Funding Amount
$2,527,082.00
Summary
Our CRE is based on common respiratory conditions covering wide spectrum of ages and severity. We will investigate how to maintain optimal respiratory health, through innovative approaches to early detection, improved therapy and adherence. We have a strong multi-disciplinary team of collaborators and we will build capacity through post-doctoral fellowships to improve our structural balance and optimise translational outputs. Tasmania is an ideal community to host a strong CCRE.
NHMRC Centre Of Research Excellence For Better Outcomes In Coronary Artery Disease
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
One Australian suffers a heart attack every 10 min, many without any prior warning. What contributes to atherosclerosis beyond traditional risk factors, and how to manage patients that suffer a heart attack despite no risk factors is not well known. This CRE will establish new biomarkers and clinical pathways for detection of subclinical atherosclerosis as well as secondary prevention strategies whilst fostering the cardiovascular research leaders of the future.